Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
McKesson
Federal Trade Commission
Healthtrust
Julphar
Fuji
Chinese Patent Office
Citi

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065308

« Back to Dashboard

NDA 065308 describes CEFUROXIME AXETIL, which is a drug marketed by Sun Pharm Inds Ltd, Alkem Labs Ltd, Ani Pharms Inc, Apotex, Aurobindo Pharma Ltd, Fosun Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, and Wockhardt, and is included in eleven NDAs. It is available from twenty-nine suppliers. Additional details are available on the CEFUROXIME AXETIL profile page.

The generic ingredient in CEFUROXIME AXETIL is cefuroxime axetil. There are sixty-one drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
Summary for 065308
Tradename:CEFUROXIME AXETIL
Applicant:Aurobindo Pharma Ltd
Ingredient:cefuroxime axetil
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 065308
Ingredient-typeCephalosporins
Suppliers and Packaging for NDA: 065308
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065308 ANDA NorthStar Rx LLC 16714-400 N 16714-400-01
CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065308 ANDA NorthStar Rx LLC 16714-400 N 16714-400-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 125MG BASE
Approval Date:Mar 29, 2006TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 250MG BASE
Approval Date:Mar 29, 2006TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 500MG BASE
Approval Date:Mar 29, 2006TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Merck
QuintilesIMS
Fuji
Colorcon
McKinsey
Citi
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.